Banner Alzheimer’s Institute Receives Added NIH Support – Five-year funding expected to total $14.8 million to support groundbreaking Alzheimer’s Prevention InitiativeContinue reading→

Allscripts shareholders elected biotech industry executive Mara G. Aspinall  to  the company’s Board of Directors.  Continue reading→

Continue reading→

Sergio Gazic, former Bioscience Portfolio Manager at the Arizona Commerce Authority, began his  new role as Chief Executive Officer of BioAccel on Monday, May 22, 2017. Continue reading→

EpiFinder, Inc., announced its proprietary clinical decision analytics software to improve epilepsy syndrome diagnosis and seizure event management at the point-of-care. The early-stage Arizona company provides intelligent analytics and support to doctors, neurologists and healthcare professionals (Nurse Practitioners, Physician Assistants, and more) to enhance the lives of patients with epilepsy.Continue reading→

Accelerate Diagnostics, Inc. (Nasdaq:AXDX), is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and healthcare-associated infections.Continue reading→

 On May 12, 2017, Governor Doug Ducey signed Arizona’s $9.8 billion 2018-2019 Budget which provides bonding authority for $1 billion for investments in University Research Infrastructure.    This investment continues a collaboration between the State of Arizona, Industry Leaders, Philanthropists, and Arizona’s Universities that is driving Arizona towards its goal of becoming a top-tier bioscience state.Continue reading→

The White Hat Life Science Investor Conference is hosted by AZBio and its regional partners in California, Colorado, Montana, New Mexico, and Utah in even numbered years.  In odd numbered years, the region hosts the Rocky Mountain Life Science Investor and Partnering Conference in Colorado.  Application are currently open for the October conference in Vail. Continue reading→